Definium’s LSD Depression Drug Sends Shares Soaring After Breakthrough Trial Results

*Feature Image : NY Post, Reuters Definium Therapeutics just shook both biotech and mental health spaces in a big way. The company’s shares [NASDAQ: DFTX] surged more than 50% after its LSD-based depression treatment delivered strong late-stage trial results, signaling a potential shift in how we treat major depressive disorder. The drug, known as DT120, […] The post Definium’s LSD Depression Drug Sends Shares Soaring After Breakthrough Trial Results appeared first on EDMTunes.